 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jun 08, 2011 |
| Title |
HNF4A-binding sites in HepG2 hepatoblastoma cells treated with TGF-beta |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
Specific regulation of target genes by transforming growth factor-β (TGF-β) in a given cellular context is determined in part by transcription factors and cofactors that interact with the Smad complex. In the present study, we determined Smad2 and Smad3 (Smad2/3) binding regions in the promoters of known genes in HepG2 hepatoblastoma cells, and compared them to those in HaCaT epidermal keratinocytes to elucidate the mechanisms of cell type- and context-dependent regulation of transcription induced by TGF-β. Our results show that 81% of the Smad2/3 binding regions in HepG2 cells were not shared with those found in HaCaT cells. Hepatocyte nuclear factor 4α (HNF4α) is expressed in HepG2 cells, but not in HaCaT cells, and the HNF4α binding motif was identified as an enriched motif in the HepG2-specific Smad2/3 binding regions. ChIP-sequencing analysis of HNF4A binding regions under TGF-β stimulation revealed that 32.5% of the Smad2/3 binding regions overlapped HNF4A bindings. MIXL1 was identified as a new combinatorial target of HNF4A and Smad2/3, and both the HNF4A protein and its binding motif were required for the induction of MIXL1 by TGF-β in HepG2 cells. These findings generalize the importance of binding of HNF4A on Smad2/3 binding genomic regions for HepG2-specific regulation of transcription by TGF-β, and suggest that certain transcription factors expressed in a cell-type-specific manner play important roles in the transcription regulated by the TGF-β-Smad signaling pathway.
|
| |
|
| Overall design |
HepG2 cells were treated with TGF-beta for 1.5 h or left untreated. anti-HNF4A ChIP-seq was performed. One lane was used for each sample.
|
| |
|
| Contributor(s) |
Mizutani A, Koinuma D, Tsutsumi S, Kamimura N, Morikawa M, Suzuki H, Miyazono K, Aburatani H |
| Citation(s) |
21646355 |
| |
| Submission date |
Apr 25, 2011 |
| Last update date |
Dec 03, 2018 |
| Contact name |
Daizo Koinuma |
| E-mail(s) |
[email protected]
|
| Organization name |
University of Tokyo
|
| Department |
Pathology
|
| Street address |
Hongo 7-3-1, Bunkyo-ku
|
| City |
Tokyo |
| ZIP/Postal code |
113-0033 |
| Country |
Japan |
| |
|
| Platforms (1) |
| GPL9115 |
Illumina Genome Analyzer II (Homo sapiens) |
|
| Samples (2) |
| GSM714326 |
HepG2_no stimulation_HNF4A_ChIPSeq |
| GSM714327 |
HepG2_TGF-beta stimulation_HNF4A_ChIPSeq |
|
| This SubSeries is part of SuperSeries: |
| GSE28798 |
Cell-type-specific target selection by combinatorial binding of Smad2/3 and hepatocyte nuclear factor 4-alpha in HepG2 cells |
|
| Relations |
| BioProject |
PRJNA143117 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE28845_RAW.tar |
39.3 Mb |
(http)(custom) |
TAR (of BED, WIG) |
| Processed data provided as supplementary file |
| Raw data provided as supplementary file |
|
|
|
|
 |
